2.81k followers • 11 symbols Watchlist by Yahoo Finance
This basket consists of stocks that benefit from the needs of aging baby boomers.
Curated by Yahoo Finance
Baby boomers — people born between 1946 and and 1964 — represent nearly 25% of the US population, and the number of Americans over 65 is projected to double by 2060. Many of the companies on this list serve senior citizens’ needs, including recreational activities, health care, and end-of-life planning.How did we choose these stocks?
Each of these stocks was chosen by the Yahoo Finance editorial staff.Who made these selections?
Yahoo Finance is the most-read business website in the US, garnering roughly 75 million unique visitors every month. The site has extensive coverage of the markets, travel, technology and general business.How are these weighted?
The stocks in this watchlist are weighted equally.
|Watchlist||Change Today||1 Month Return||1 Year Return||Total Return|
|Aging Baby Boomers||+0.15%||-6.75%||-28.37%||-15.44%|
|Symbol||Company Name||Last Price||Change||% Change||Market Time||Volume||Avg Vol (3 month)||Market Cap|
|UNH||UnitedHealth Group Incorporated||356.65||+5.81||+1.66%||11:20 a.m. EST||1.39M||3.23M||338.40B|
|PG||The Procter & Gamble Company||130.943||-0.20||-0.15%||11:20 a.m. EST||3.18M||6.78M||324.69B|
|RCL||Royal Caribbean Group||71.97||-0.85||-1.17%||11:20 a.m. EST||990.06k||5.83M||17.08B|
|SCI||Service Corporation International||52.215||+0.35||+0.68%||11:19 a.m. EST||143.96k||827.76k||9.02B|
|HI||Hillenbrand, Inc.||43.67||-0.06||-0.14%||11:19 a.m. EST||45.81k||434.66k||3.28B|
|MATW||Matthews International Corporation||31.32||-0.01||-0.03%||11:09 a.m. EST||28.58k||166.92k||995.71M|
|IVC||Invacare Corporation||10.12||-0.28||-2.69%||11:18 a.m. EST||20.54k||219.05k||348.25M|
|LPNT||LifePoint Health, Inc.||-||-||-||6:07 p.m. EDT||-||-||-|
|HCN||-||-||-||-||6:07 p.m. EDT||-||-||-|
UnitedHealth Group (UNH) reported better-than-expected fourth-quarter 2020 results wherein it breezed past the Zacks Consensus Estimate on both earnings and revenues.
The Canadian dollar strengthened to a near three-year high against its U.S. counterpart on Thursday, tracking gains for stock markets globally even as U.S. President Joe Biden formally revoked the permit needed to build the Keystone XL oil pipeline. World stocks racked up record highs and the U.S. dollar fell as investors bet major stimulus from Biden and unswerving global central bank support would cushion the coronavirus's economic damage. The Canadian dollar was trading 0.1% higher at 1.2613 to the greenback, or 79.28 U.S. cents, having touched its strongest intraday level since April 2018 at 1.2590.
UnitedHealth Group reported better-than-expected fourth-quarter results despite a spike in pandemic-led healthcare costs. The healthcare giant’s 4Q sales rose 7.5% to $65.5 billion year-on-year, exceeding consensus estimates of $65.1 billion. Shares closed at $350.84 on Jan. 20. UnitedHealth (UNH) posted 4Q adjusted earnings of $2.52 per share, which beat analysts’ estimates of $2.40 per share. The company’s 4Q net EPS (earnings per share) of $2.30 fell from the $3.68 posted during the same quarter last year. Its adjusted EPS of $2.52 per share declined from $3.90 in 4Q19. This decline in earnings per share was largely related to higher healthcare costs due to Covid-19, the company said. For FY20, revenue rose 6% to $257.1 billion year-on-year, led by a 21% uptick in sales at its Optum business. Optum is UnitedHealth’s information technology-enabled health services business that serves different dimensions of the healthcare system including care providers, life sciences companies, and consumers. (See UNH stock analysis on TipRanks) UnitedHealth’s CEO, David S. Wichmann, commented, “We are grateful for the human spirit and resolve of our people, including our 125,000 clinicians who, with other frontline health care workers, demonstrated extraordinary collaboration, compassion and innovation.” The company affirmed its FY21 earnings outlook and expects net earnings of between $16.90 to $17.40 per share and adjusted net earnings of between $17.75 to $18.25 per share. According to UnitedHealth, this outlook includes a negative impact of approximately $1.80 per share due to Covid-19 that included testing and treatment costs and people deferring healthcare in 2020. Following the 4Q results, Oppenheimer analyst Michael Wiederhorn reiterated a Buy rating on the stock and set a price target of $375. “The company’s Optum business is a nice complement to its core managed care operations and continues to account for a large share of earnings,” Wiederhorn commented in a note to investors. Furthermore, UNH’s vertical integration strategy strengthens the company’s competitive positioning across many areas of the healthcare landscape.” Overall, analysts are bullish about the stock and the consensus is a Strong Buy with 16 analysts suggesting a Buy and 2 analysts recommending a Hold. The average price target of $396.44 implies 13% upside potential to current levels. Related News:Aclaris Explodes 220% On ‘Positive Data’ From Rheumatoid Arthritis TrialAkzo Nobel Enters Tikkurila Takeover Battle With $1.7B BidMasterCraft Is Going Digital For Its Dynamic Boat Show Season More recent articles from Smarter Analyst: 2 “Strong Buy” Penny Stocks That Could See Outsized Gains United Airlines Posts Wider-Than Feared Loss of $1.9B In 4Q; Street Says Hold Thursday’s Pre-Market: Here’s What You Need To Know Before The Market Opens Inovio Sinks 7% After Pricing Of $150.5M Share Offering; Street Says Hold